HistoSonics: Valuation, Funding & Investors
HistoSonics is a privately held medical device company developing a non-invasive platform and proprietary sonic beam therapy utilizing the science of histotripsy, a novel mechanism of action that uses focused ultrasound to mechanically destroy and liquefy unwanted tissue and tumors. The company is currently focused on commercializing their Edison System in the US and select global markets for liver treatment while expanding histotripsy applications into other organs like kidney, pancreas, prostate, and others.
Leadership & Board
Key Executives
- President and CEO
- Mike Blue
- Chief Operating Officer
- Christine Gibbons
- Chairman
- Josh Makower
- Chief Financial Officer
- Samir Saini
- Chief Medical Officer
- Michael Laufer
- Current Number of Employees
- 477
- Current LinkedIn Followers
- 33,084
Latest Estimated Valuation
- Total Amount Raised
- $250M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $250M
- Latest Funding Round
- Growth Round
Employee Trend
HistoSonics had 477 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
HistoSonics had 33,084 followers as of October 26, 2026. The number of followers increased by 205 (0.62%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Oct 16, 2025 | Growth Round | $250.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Founders Fund | Growth Round |
| K5 Global | Growth Round |
| Bezos Expeditions | Growth Round |
| Wellington Management | Growth Round |
| Thiel Bio | Growth Round |
Similar Companies
A snapshot of private companies similar to HistoSonics, helping you discover and navigate related company profiles.
Related News and Analysis
